ArticleCurrent microbiology2026
An Optimized and Systematically Integrated Expression, Extraction, and Purification Strategy Enabling Efficient Production of TCR-Like Antibodies in Escherichia coli.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Efficient bacterial production of recombinant antibody fragments is critical for structural characterization and subsequent functional studies. In this study, a systematically optimized workflow was developed for the expression, extraction, and purification of soluble T-cell receptor (TCR)-like antibody fragments in Escherichia coli (E. coli). Two expression hosts, the K-12-derived HB2151 strain and the B-lineage BL21(DE3) pLysS strain, were comparatively evaluated. Although both strains supported recombinant expression, BL21(DE3) pLysS produced higher levels of soluble protein. However, conventional osmotic shock extraction resulted in limited protein recovery. To improve extraction efficiency, a combined lysis approach incorporating freeze-thaw cycles, lysozyme treatment, and sonication was applied, increasing total protein recovery in cell lysates to 149.2-178.4 mg/L of culture. Purification was carried out using Protein A affinity chromatography, and the purification conditions were further optimized to enhance protein recovery. Optimal binding was achieved using 20 mM sodium phosphate buffer (pH 6.8), while elution with 100 mM citric acid (pH 2.9) improved protein yield while maintaining protein stability during purification. Under these conditions, purified soluble TCR-like antibody fragments were obtained at final yields of 6.16-7.08 mg/L of culture. The purified proteins migrated at the expected molecular weight (~ 15 kDa) on SDS-PAGE and were specifically detected by dot blot analysis. Overall, this study provides a reproducible and scalable workflow for improving the expression, extraction, and purification of recombinant soluble TCR-like antibody fragments in E. coli.
Indexed as
Identifiers
42301531What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.